ImportRefusal LogoImportRefusal

ALLERGAN

⚠️ High Risk

FEI: 3019006133 • Annecy • FRANCE

FEI

FEI Number

3019006133

📍

Location

Annecy

🇫🇷

Country

FRANCE
🏢

Address

Rte De Promery - Za De, , Annecy, , France

High Risk

FDA Import Risk Assessment

54.3
LowModerateHighCritical

This firm has a significant history of FDA import refusals with notable violations.

Statistics

6
Total Refusals
6
Unique Violations
11/12/2025
Latest Refusal
6/25/2021
Earliest Refusal

Score Breakdown

Violation Severity
60.6×40%
Refusal Volume
31.3×30%
Recency
96.3×20%
Frequency
13.7×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

1185×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

32805×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.

24803×

RXPERSONAL

The article appears to be a device which requires a prescription from your doctor.

2372×

NO PMA

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the device appears to be a Class III device and does not appear to have in effect an approved application for premarket approval pursuant to Section 515 of the Act, or an exemption pursuant to Section 520(g)(1).

751×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

841×

RX DEVICE

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it is a prescription device that appears to not feature a prescription device legend as required by 21 CFR 801.109.

Refusal History

DateProductViolationsDivision
11/12/2025
53LY99OTHER SKIN CARE PREPARATIONS, N.E.C.
118NOT LISTED
237NO PMA
3280FRNMFGREG
75UNAPPROVED
Division of Southeast Imports (DSEI)
8/8/2025
60QBL07LIDOCAINE
118NOT LISTED
3280FRNMFGREG
Division of Northeast Imports (DNEI)
5/5/2022
79LMHIMPLANT, DERMAL, COLLAGEN FOR AESTHETIC USE
84RX DEVICE
Division of Southeast Imports (DSEI)
3/3/2022
79LMHIMPLANT, DERMAL, COLLAGEN FOR AESTHETIC USE
118NOT LISTED
237NO PMA
2480RXPERSONAL
3280FRNMFGREG
Division of Southeast Imports (DSEI)
7/20/2021
79LMHIMPLANT, DERMAL, COLLAGEN FOR AESTHETIC USE
118NOT LISTED
2480RXPERSONAL
3280FRNMFGREG
Division of Northern Border Imports (DNBI)
6/25/2021
79LMHIMPLANT, DERMAL, COLLAGEN FOR AESTHETIC USE
118NOT LISTED
2480RXPERSONAL
3280FRNMFGREG
Division of Northern Border Imports (DNBI)

Frequently Asked Questions

What is ALLERGAN's FDA import refusal history?

ALLERGAN (FEI: 3019006133) has 6 FDA import refusal record(s) in our database, spanning from 6/25/2021 to 11/12/2025.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. ALLERGAN's FEI number is 3019006133.

What types of violations has ALLERGAN received?

ALLERGAN has been cited for 6 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about ALLERGAN come from?

All FDA import refusal data for ALLERGAN is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.